These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 29297746)

  • 1. Influenza vaccines: Evaluation of the safety profile.
    Trombetta CM; Gianchecchi E; Montomoli E
    Hum Vaccin Immunother; 2018 Mar; 14(3):657-670. PubMed ID: 29297746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and safety of influenza vaccination in children: European perspective.
    Heikkinen T; Heinonen S
    Vaccine; 2011 Oct; 29(43):7529-34. PubMed ID: 21820481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative efficacy of inactivated and live attenuated influenza vaccines.
    Monto AS; Ohmit SE; Petrie JG; Johnson E; Truscon R; Teich E; Rotthoff J; Boulton M; Victor JC
    N Engl J Med; 2009 Sep; 361(13):1260-7. PubMed ID: 19776407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seasonal influenza vaccines.
    Fiore AE; Bridges CB; Cox NJ
    Curr Top Microbiol Immunol; 2009; 333():43-82. PubMed ID: 19768400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and immunogenicity of live attenuated and inactivated influenza vaccines in children with cancer.
    Carr S; Allison KJ; Van De Velde LA; Zhang K; English EY; Iverson A; Daw NC; Howard SC; Navid F; Rodriguez-Galindo C; Yang J; Adderson EE; McCullers JA; Flynn PM
    J Infect Dis; 2011 Nov; 204(10):1475-82. PubMed ID: 21949042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative safety, immunogenicity, and efficacy of several anti-H5N1 influenza experimental vaccines in a mouse and chicken models (Testing of killed and live H5 vaccine).
    Gambaryan AS; Lomakina NF; Boravleva EY; Kropotkina EA; Mashin VV; Krasilnikov IV; Klimov AI; Rudenko LG
    Influenza Other Respir Viruses; 2012 May; 6(3):188-95. PubMed ID: 21951678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The status of vaccinal prophylaxis against influenza today].
    Bichurina MA; Fridman EA
    Zh Mikrobiol Epidemiol Immunobiol; 1996; (6):104-8. PubMed ID: 9103060
    [No Abstract]   [Full Text] [Related]  

  • 8. Influenza vaccine for chronic obstructive pulmonary disease (COPD).
    Kopsaftis Z; Wood-Baker R; Poole P
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD002733. PubMed ID: 29943802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different influenza vaccine formulations and adjuvants for childhood influenza vaccination.
    Esposito S; Principi N
    Vaccine; 2011 Oct; 29(43):7535-41. PubMed ID: 21820478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influenza vaccines in children.
    Neuzil KM; Edwards KM
    Semin Pediatr Infect Dis; 2002 Jul; 13(3):174-81. PubMed ID: 12199613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma.
    Fleming DM; Crovari P; Wahn U; Klemola T; Schlesinger Y; Langussis A; Øymar K; Garcia ML; Krygier A; Costa H; Heininger U; Pregaldien JL; Cheng SM; Skinner J; Razmpour A; Saville M; Gruber WC; Forrest B;
    Pediatr Infect Dis J; 2006 Oct; 25(10):860-9. PubMed ID: 17006278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial.
    Bernstein DI; Guptill J; Naficy A; Nachbagauer R; Berlanda-Scorza F; Feser J; Wilson PC; Solórzano A; Van der Wielen M; Walter EB; Albrecht RA; Buschle KN; Chen YQ; Claeys C; Dickey M; Dugan HL; Ermler ME; Freeman D; Gao M; Gast C; Guthmiller JJ; Hai R; Henry C; Lan LY; McNeal M; Palm AE; Shaw DG; Stamper CT; Sun W; Sutton V; Tepora ME; Wahid R; Wenzel H; Wohlbold TJ; Innis BL; García-Sastre A; Palese P; Krammer F
    Lancet Infect Dis; 2020 Jan; 20(1):80-91. PubMed ID: 31630990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Live attenuated and inactivated influenza vaccines: data from direct comparative studies].
    Kashirina OS; Vasil'ev IuM
    Zh Mikrobiol Epidemiol Immunobiol; 2014; (1):103-19. PubMed ID: 24738303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Postmarket Safety Profile of Adjuvanted and High-Dose Influenza Vaccines in Individuals 65 Years or Older.
    Pillsbury AJ; Fathima P; Quinn HE; Cashman P; Blyth CC; Leeb A; Macartney KK
    JAMA Netw Open; 2020 May; 3(5):e204079. PubMed ID: 32369177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and safety of Southern Hemisphere inactivated quadrivalent influenza vaccine: a Phase III, open-label study of adults in Brazil.
    Zerbini CA; Ribeiro Dos Santos R; Jose Nunes M; Soni J; Li P; Jain VK; Ofori-Anyinam O
    Braz J Infect Dis; 2017; 21(1):63-70. PubMed ID: 27912069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of trivalent inactivated influenza vaccine in young children: a summary for the new era of routine vaccination.
    Zangwill KM; Belshe RB
    Pediatr Infect Dis J; 2004 Mar; 23(3):189-97. PubMed ID: 15014289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal live attenuated seasonal influenza vaccine: does not challenge current practice.
    Prescrire Int; 2013 Sep; 22(141):201-4. PubMed ID: 24171209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine effectiveness of live attenuated and trivalent inactivated influenza vaccination in 2010/11 to 2015/16: the SIVE II record linkage study.
    Simpson CR; Lone NI; Kavanagh K; Englishby T; Robertson C; McMenamin J; Wissman BV; Vasileiou E; Butler CC; Ritchie LD; Gunson R; Schwarze J; Sheikh A
    Health Technol Assess; 2020 Dec; 24(67):1-66. PubMed ID: 33256892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shedding of live vaccine virus, comparative safety, and influenza-specific antibody responses after administration of live attenuated and inactivated trivalent influenza vaccines to HIV-infected children.
    Levin MJ; Song LY; Fenton T; Nachman S; Patterson J; Walker R; Kemble G; Allende M; Hultquist M; Yi T; Nowak B; Weinberg A
    Vaccine; 2008 Aug; 26(33):4210-7. PubMed ID: 18597900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety, immunogenicity and infectivity of new live attenuated influenza vaccines.
    Isakova-Sivak I; Rudenko L
    Expert Rev Vaccines; 2015; 14(10):1313-29. PubMed ID: 26289975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.